MiNK Therapeutics(INKT) - 2022 Q4 - Earnings Call Transcript

MiNK Therapeutics, Inc. (NASDAQ:INKT) Q4 2022 Results Conference Call March 21, 2023 8:30 AM ET Company Participants Zack Armen - Head of Investor Relations at MiNK Jennifer Buell - President and Chief Executive Officer Christine Klaskin - Principal Financial and Accounting Officer Conference Call Participants Emily Bodnar - H.C. Wainwright Kalpit Patel - B. Riley Jack Allen - Baird Matt Phipps - William Blair Operator Good morning, and welcome to MiNK Therapeutics' Fourth Quarter and Full Year 2022 Confere ...